These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of aerosolized artificial surfactant on repeated oleic acid injury in sheep. Zelter M; Escudier BJ; Hoeffel JM; Murray JF Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):1014-9. PubMed ID: 2327634 [TBL] [Abstract][Full Text] [Related]
7. Criteria for use of colfosceril (Exosurf) in neonates. Bhatt-Mehta V; Schumacher RE Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234 [No Abstract] [Full Text] [Related]
8. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470 [TBL] [Abstract][Full Text] [Related]
9. Lung function in prematurely delivered rabbits treated with a synthetic surfactant. Tooley WH; Clements JA; Muramatsu K; Brown CL; Schlueter MA Am Rev Respir Dis; 1987 Sep; 136(3):651-6. PubMed ID: 3307569 [TBL] [Abstract][Full Text] [Related]
10. Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. Phibbs RH; Ballard RA; Clements JA; Heilbron DC; Phibbs CS; Schlueter MA; Sniderman SH; Tooley WH; Wakeley A Pediatrics; 1991 Jul; 88(1):1-9. PubMed ID: 2057244 [TBL] [Abstract][Full Text] [Related]
11. Lavage administration of dilute surfactants after acute lung injury in neonatal piglets. Balaraman V; Meister J; Ku TL; Sood SL; Tam E; Killeen J; Uyehara CF; Egan E; Easa D Am J Respir Crit Care Med; 1998 Jul; 158(1):12-7. PubMed ID: 9655700 [TBL] [Abstract][Full Text] [Related]
12. Surfactant improves gas mixing and alveolar ventilation in preterm lambs. Sandberg K; Edberg KE; Benton W; Silberberg A; Sladek M; Sundell HW Pediatr Res; 1991 Aug; 30(2):181-9. PubMed ID: 1896264 [TBL] [Abstract][Full Text] [Related]
13. Surfactant therapy in respiratory distress syndrome--the first local experience. Lim NL; Nordin MM; Cheah IG Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989 [TBL] [Abstract][Full Text] [Related]
14. Comparison of poractant alfa and lyophilized lucinactant in a preterm lamb model of acute respiratory distress. Mazela J; Merritt A; Terry MH; Gregory TJ; Blood AB Pediatr Res; 2012 Jul; 72(1):32-7. PubMed ID: 22465908 [TBL] [Abstract][Full Text] [Related]
16. Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf). Pfenninger J; Aebi C; Bachmann D; Wagner BP Pediatr Pulmonol; 1992 Sep; 14(1):10-5. PubMed ID: 1437337 [TBL] [Abstract][Full Text] [Related]
17. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. Anzueto A; Baughman RP; Guntupalli KK; Weg JG; Wiedemann HP; Raventós AA; Lemaire F; Long W; Zaccardelli DS; Pattishall EN N Engl J Med; 1996 May; 334(22):1417-21. PubMed ID: 8618579 [TBL] [Abstract][Full Text] [Related]
18. Dexamethasone enhances the activity of rSP-C surfactant but not of exosurf in a rat model of the acute lung injury. Häfner D; Germann PG J Pharmacol Toxicol Methods; 1999 Sep; 42(1):39-48. PubMed ID: 10715602 [TBL] [Abstract][Full Text] [Related]